Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label atlas of genetics. Show all posts
Showing posts with label atlas of genetics. Show all posts
Friday, January 20, 2012

Norway Launches National Cancer Genomic Medicine Effort | GenomeWeb

›
Blogger's Note : requires registration to view (free) NEW YORK (GenomeWeb News) – "Norway has kicked off a national collaborativ...
Thursday, January 19, 2012

Hereditary ovarian cancer: Beyond the usual suspects - abstract (Fanconi anemia–BRCA,PARP, RAD51C, RAD51D,BRIP1

›
Blogger's Note: see post Myriad Genetics  rights/RAD51C .....With at least 16 genes implicated in hereditary ovarian cancer to dat...
Monday, January 16, 2012

abstract: Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer

›
BACKGROUND: Germline mutations in the BRCA2 cancer susceptibility gene are associated with an increased risk of pancreatic cancer (PC...
Wednesday, January 11, 2012

The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer

›
Abstract The genetic basis for gastric and pancreatic cancer is largely undetermined. These cancers are overrepresented in heredita...
Saturday, December 31, 2011

Factors Associated with Altered Long-Term Well-Being After Prophylactic Salpingo-Oophorectomy Among Women at Increased Hereditary Risk for Breast and Ovarian Cancer

›
Blogger's note : full view may require $$$ (subscription) link to abstract
Monday, August 22, 2011

free full access: Variants of Uncertain Significance in Breast Cancer–Related Genes: Real-World Implications for a Clinical Conundrum. Part One: Clinical Genetics Recommendations

›
Variants of Uncertain Significance in Breast Cancer–Related Genes: Real-World Implications for a Clinical Conundrum. Part One: Clinical ...

abstract: Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples

›
Saturday, August 13, 2011

The predicted truncation from a (ovarian) cancer-associated variant of the MSH2 initiation codon alters activity of the MSH2-MSH6 mismatch repair complex

›
Abstract Lynch syndrome (LS) is caused by germline mutations in DNA mismatch repair (MMR) genes. MMR recognizes and repairs DNA mismat...
Thursday, August 04, 2011

Cancer Genome Atlas (press release July 2011) TCGA Completes Ovarian Cancer (serous) Analysis - TCGA plus link to video discussion

›
To view a video of Dr. Spellman discussing TCGA and the ovarian cancer findings, please go to http://www.youtube.com/watch?v=TK_CIGEUHxU
Friday, July 01, 2011

Detailed 'genetic landscape' of ovarian cancer revealed : Cancer Research UK

›
Note : nice 'plain english language' article
Thursday, June 30, 2011

medical news: Sequence of ovarian genome identifies predominant gene mutations, points to possible treatment

›
"....While high-grade serous ovarian adenocarcinoma is conventionally considered as one type of cancer having uniform features, ...
Wednesday, June 29, 2011

The Cancer Genome Atlas completes detailed ovarian cancer analysis - GenOmics

›
also: A more detailed press release on the study will be available from the National Institutes of Health at http://nih.gov/news/ .
Sunday, June 05, 2011

extract: Cancer Risk Assessment in Lynch Syndrome, June 8, 2011 — JAMA

›
Thursday, March 10, 2011

News - Penn State Biochemistry and Molecular Biology Colorectal Cancer month/Lynch Syndrome excerpt

›
" Lynch syndrome, previously referred to as hereditary non-polyposis colorectal cancer or HNPCC , represents the most common hereditar...
3 comments:

March 2011: Hereditary Cancer in Clinical Practice | Full text | Lynch Syndrome - is breast cancer a feature?

›
Background The debate on whether or not breast cancer is in the tumor spectrum for Lynch syndrome produces a conundrum for healthcare prov...
Sunday, February 20, 2011

Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer.

›
PURPOSE: Paclitaxel has a broad spectrum of anti-tumor activity and is useful in the treatment of ovarian, breast, and lung cancer. Pacli...
Monday, January 24, 2011

Atlas of Genetics and Cytogenetics in Oncology and Haematology - Ovarian tumours : an overview

›